Plasmablastic lymphoma in a previously undiagnosed aids patient: A case report

Head and Neck Pathology

Volumn 2, Issue 2, 2008, Pages 92-96

  Vieira, Francisco O ^a,b   El Gandour, Omar ^a   Buadi, Francis K ^c   Williams, Glenn B ^a   Shires, Courtney B ^a   Zafar, Nadeem ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Regional Medical Center Memphis   (United States)

^c MAYO CLINIC   (United States)

Author keywords

AIDS; HAART; HIV; Non Hodgkin lymphoma; Plasmablastic lymphoma; Radiotherapy

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; TUMOR MARKER;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADJUVANT THERAPY; ADULT; ARTICLE; B CELL LYMPHOMA; CASE REPORT; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; METABOLISM; METHODOLOGY; MOUTH TUMOR; MULTIMODALITY CANCER THERAPY; PATHOLOGY; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHOMA, AIDS-RELATED; MOUTH NEOPLASMS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 77957336066     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-008-0058-1     Document Type: Article

References (34)

1. Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood. 1997;89:1413-20.
2. Biggar RJ. AIDS-related cancers in the era of highly active antiretroviral therapy. Oncology. 2001;15:439-48.
3. Eltom MA, Jemal A, Mbulaiteye SM, et al. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst. 2002;94:1204-10.
4. Nasta SD, Carrum GM, Shahab I, et al. Regression of plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy. Leuk Lymphoma. 2002;43:423-6.
5. Berretta M, Cinelli R, Martellotta F, et al. Therapeutic approaches to AIDS-related malignancies. Oncogene. 2003;42:6646-59.
6. Cioc AM, Allen C, Kalmar JR, et al. Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8 Am J Surg Pathol. 2004;28:41-6.
7. Diamond C, Taylor TH, Aboumrad T, et al. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival. Cancer. 2006;106:128-35.
8. Appleby P, Beral V, Carpenter L, et al. The impact of highly active antiretroviral therapy and the incidence of cancer in people infected with the human immunodeficiency virus. International collaboration on HIV and cancer unit. J Natl Cancer Inst. 2000;92:1823-30.
9. Gates A, Kaplan L. AIDS malignancies in the era of highly active antiretroviral therapy. Oncology (Huntingt). 2002;16:441-51.
10. Teruya-Feldstein J, Chiao E, Filippa DA, et al. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogeneous spectrum in both HIV-positive and-negative patients. Ann Oncol. 2004;15:1673-9.
11. Chetty R, Hlatswayo N, Sabaratnam R, et al. Plasmablastic lymphoma in HIV+ patients: an expanding spectrum. Histopathology. 2003;42:605-9.
12. Duarte ECB, Silveira-Junior JB, Gomez RS, et al. Plasmablastic lymphoma of oral mucosa type: a case report. Oral Oncol Extra. 2005;41:121-4.
13. Porter SR, Diz Dios P, Kumar N, et al. Oral plasmablastic lymphoma in previously undiagnosed HIV disease. Oral Surg Oral Med Oral Radiol Endod. 1999;87:730-4.
14. Antinori AA, Cingolani AB, Alba LA, et al. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy. AIDS 2001;15:1483-91.
15. Little RF, Pittaluga S, Grant N, et al. Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood. 2003;101:4653-9.
16. Lin Y, Rodrigues GD, Turner JF, et al. Plasmablastic lymphoma of the lung. Report of a unique case and review of the literature. Arch Pathol Lab Med. 2001;125:282-5.
17. Lin F, Zhang K, Quiery AT Jr, et al. Plasmablastic lymphoma of cervical lymph nodes in a human immunodeficiency virus-negative patient. A case report and review of the literature. Arch Pathol Lab Med. 2004;128:581-4.
18. Scheper MA, Nikitakis NG, Fernandes R, et al. Oral plasmablastic lymphoma in an HIV-negative patient: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:198-206.
19. Nguyen DD, Loo BW, Tillman G, et al. Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report. Ann Hematol. 2003;82:512-5.
20. Lester R, Phillips P, Shenkier TN, et al. Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of two cases. Leuk Lymphoma. 2004;45:1881-5.
21. Brown RS, Cambell C, Lishman SC, et al. Plasmablastic lymphoma: a new subcategory of human immunodeficiency virusrelated non-Hodgkin's lymphoma. Clin Oncol (R Coll Radiol). 1998;10:327-9.
22. Desai RS, Vanaki SS, Puranik RS, et al. Plasmablastic lymphoma presenting as gingival growth in a previously undiagnosed HIVpositive patient: a case report. J Oral Maxillofac Surg 2007;65:1358-61.
23. Diamond C, Taylor TH, Aboumrad T, et al. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy. Cancer. 2005;106:128-35.
24. Gates A, Kaplan L. AIDS malignancies in the era of highly active antiretroviral therapy. Oncol (Huntingt). 2002;16:657-65.
25. Noy A. Update in HIV-associated lymphoma. Curr Opin Oncol. 2004;16:450-4.
26. Levine AM, Seneviratne L, Tulpule A. Incidence and management of AIDS-related lymphoma. Oncology (Williston Park). 2001;15:629-39.
27. Vaccher E, Spina M, di Gennaro G, et al. Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin's lymphoma. Cancer. 2001;91:155-63.
28. Navarro WH, Kaplan LD. AIDS-related lymphoproliferative disease. Blood. 2006;107:13-20.
29. Gaidano G, Cerri M, Capelo D, et al. Molecular histogenesis of plasmablastic lymphoma of the oral cavity. Br J Haematol. 2002;119:622-8.
30. Dong HY, Scadden DT, de Leval L, Tang Z, et al. Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol. 2005;29:1633-41.
31. Redmond M, Quinn J, Murphy P, et al. Plasmablastic lymphoma presenting as a paravertebral mass in a patient with Crohn's disease after immunosuppressive therapy. J Clin Pathol. 2007;60:80-1.
32. Pruneri G, Graziadei G, Ermellino L, et al. Plasmablastic lymphoma of the stomach. A case report. Haematologica. 2008;83(1):87-9.
33. Tavora F, Gonzalez-Cuyar LF, Sun CJ, et al. Extra-oral plasmablastic lymphoma: report of a case and review of literature. Hum Pathol. 2006;37(9):1233-6.
34. Schichman SA, McClure R, Schaefer RF, Mehta P. HIV and plasmablastic lymphoma manifesting in anus, testicles and bones: a further expansion of the disease spectrum. Am J Hematol. 2004;77:291-5.